Opicapone as adjunct to levodopa in treated Parkinson's disease without motor complications: A randomized clinical trial
Treatment with once-daily adjunct opicapone was well tolerated, improved motor severity, and did not induce the development of motor complications. These results support the clinical usefulness of opicapone in the management of PD patients without motor complications.
Authors
- Joaquim José Ferreira (ORCID: https://orcid.org/0000-0003-3950-5113)
- Fabrizio Stocchi (ORCID: https://orcid.org/0000-0002-5763-0033)
- Angelo Antonini (ORCID: https://orcid.org/0000-0003-1040-2807)
- Olivier Rascol (ORCID: https://orcid.org/0000-0002-1410-6397)
- Werner Poewe (ORCID: https://orcid.org/0000-0003-4367-0971)
- José‐Francisco Rocha (ORCID: https://orcid.org/0000-0003-2611-4850)
- Guillermo Castilla‐Fernández
- Joerg Holenz
- Joana Moreira
Institutions
- Bial (Portugal) (PT)
- University of Padua (IT)
- Innsbruck Medical University (AT)
- Vita-Salute San Raffaele University (IT)
- Inserm (FR)
- Universität Innsbruck (AT)
- Centre de Recherches en Cancérologie de Toulouse (FR)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- French Clinical Research Infrastructure Network (FR)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
Publication Details
- Journal
- European Journal of Neurology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1111/ene.16420
- Citations
- 6
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 8.34